13F
← All fund report cards

AMERIPRISE FINANCIAL INC

13F equity value
$431.0B
Positions
4,012
Top 10 concentration
19.0%
Quarters / total new picks
32 / 1,745
13F equity value over time
$0M$221B$442B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +2.4% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 34.4% of quarters (excess t = -0.62, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
-0.8%
t-stat
-0.62
Quarterly win rate
34%
Annualized excess
-2.7%
$1 → follow vs universe
$1.71 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 1.00520180630: follow 0.89120180930: follow 0.94320181231: follow 0.91920190331: follow 0.87620190630: follow 0.92220190930: follow 0.97120191231: follow 0.75520200331: follow 1.00120200630: follow 1.09320200930: follow 1.40920201231: follow 1.35120210331: follow 1.39920210630: follow 1.54420210930: follow 1.37220211231: follow 1.16920220331: follow 1.27320220630: follow 1.15920220930: follow 1.23620221231: follow 1.11420230331: follow 1.10720230630: follow 1.00820230930: follow 1.30120231231: follow 1.27620240331: follow 1.22520240630: follow 1.37220240930: follow 1.35420241231: follow 1.24720250331: follow 1.28520250630: follow 1.49620250930: follow 1.63720251231: follow 1.714 0.69 1.47 2.25 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 4012 · 2026 Q1

Ticker Value Weight QoQ
NVDA $16.1B
3.7%
TRIM
AAPL $11.8B
2.7%
HOLD
MSFT $11.5B
2.7%
TRIM
GOOGL $9.5B
2.2%
TRIM
AVGO $8.2B
1.9%
ADD
AMZN $7.0B
1.6%
TRIM
JPM $5.0B
1.2%
TRIM
META $4.5B
1.1%
HOLD
LRCX $4.4B
1.0%
TRIM
IVV $4.1B
0.9%
TRIM
CVX $3.6B
0.8%
TRIM
GOOG $3.4B
0.8%
TRIM
WMT $3.4B
0.8%
TRIM
JNJ $3.4B
0.8%
ADD
V $3.3B
0.8%
TRIM
XOM $3.3B
0.8%
TRIM
BE $3.1B
0.7%
TRIM
AMAT $3.1B
0.7%
TRIM
BAC $2.8B
0.6%
TRIM
LLY $2.7B
0.6%
ADD

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.